MicroRNA-944 Affects Cell Growth by Targeting EPHA7 in Non-Small Cell Lung Cancer

被引:33
|
作者
Liu, Minxia [1 ]
Zhou, Kecheng [1 ,2 ]
Cao, Yi [1 ]
机构
[1] Chinese Acad Sci, Kunming Inst Zool, Lab Mol & Expt Pathol, Kunming 650223, Peoples R China
[2] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming 650223, Peoples R China
来源
关键词
non-small cell lung cancer (NSCLC); miR-944; regulation; cell proliferation; EPHA7; COLORECTAL-CANCER; EXPRESSION; PROMOTES; CARCINOMA; PROLIFERATION; MICROARRAY; APOPTOSIS; TISSUE; LINES; P63;
D O I
10.3390/ijms17101493
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs (miRNAs) have critical roles in lung tumorigenesis and development. To determine aberrantly expressed miRNAs involved in non-small cell lung cancer (NSCLC) and investigate pathophysiological functions and mechanisms, we firstly carried out small RNA deep sequencing in NSCLC cell lines (EPLC-32M1, A549 and 801D) and a human immortalized cell line 16HBE, we then studied miRNA function by cell proliferation and apoptosis. cDNA microarray, luciferase reporter assay and miRNA transfection were used to investigate interaction between the miRNA and target gene. miR-944 was significantly down-regulated in NSCLC and had many putative targets. Moreover, the forced expression of miR-944 significantly inhibited the proliferation of NSCLC cells in vitro. By integrating mRNA expression data and miR-944-target prediction, we disclosed that EPHA7 was a potential target of miR-944, which was further verified by luciferase reporter assay and microRNA transfection. Our data indicated that miR-944 targets EPHA7 in NSCLC and regulates NSCLC cell proliferation, which may offer a new mechanism underlying the development and progression of NSCLC.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Targeting BRAF mutations in non-small cell lung cancer
    O'Leary, Connor Gerard
    Andelkovic, Vladamir
    Ladwa, Rahul
    Pavlakis, Nick
    Zhou, Caicun
    Hirsch, Fred
    Richard, Derek
    O'Byrne, Kenneth
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (06) : 1119 - 1124
  • [22] Targeting Angiogenesis in Advanced Non-Small Cell Lung Cancer
    Lammers, Philip E.
    Horn, Leora
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (10): : 1235 - 1247
  • [23] Targeting RET alterations in non-small cell lung cancer
    Nishikawa, Go
    Klein, Mark A.
    CURRENT PROBLEMS IN CANCER, 2024, 49
  • [24] Proteolysis targeting chimeras in non-small cell lung cancer
    Hagopian, Garo
    Grant, Christopher
    Nagasaka, Misako
    CANCER TREATMENT REVIEWS, 2023, 117
  • [25] Targeting Angiogenesis in Squamous Non-Small Cell Lung Cancer
    Piperdi, Bilal
    Merla, Amartej
    Perez-Soler, Roman
    DRUGS, 2014, 74 (04) : 403 - 413
  • [26] Inhaled Medicines for Targeting Non-Small Cell Lung Cancer
    Al Khatib, Arwa Omar
    El-Tanani, Mohamed
    Al-Obaidi, Hisham
    PHARMACEUTICS, 2023, 15 (12)
  • [27] Targeting driver mutations in non-small cell lung cancer
    Vreka, Malamati
    Stathopoulos, Georgios T.
    Marazioti, Antonia
    PNEUMON, 2015, 28 (02) : 130 - 132
  • [28] Therapeutic targeting of telomerase for non-small cell lung cancer
    Frink, Robin
    Spinola, Monica
    Wright, Woodring
    Schiller, Joan
    Shay, Jerry
    Minna, John
    CANCER RESEARCH, 2009, 69
  • [29] Targeting histone deacetylases in non-small cell lung cancer
    Datta, Pran K.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S551 - S551
  • [30] Targeting the KRAS Pathway in Non-Small Cell Lung Cancer
    Tomasini, Pascale
    Walia, Preet
    Labbe, Catherine
    Jao, Kevin
    Leighl, Natasha B.
    ONCOLOGIST, 2016, 21 (12): : 1450 - 1460